Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
COVID-19 convalescent plasma (University of Pennsylvania)
- Development stage
- Unknown
- Lead developer
- University of Pennsylvania
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intravenous
01
Overview
COVID-19 convalescent plasma developed by the University of Pennsylvania is a biologic therapy consisting of plasma collected from individuals who have recovered from COVID-19. This passive immunotherapy modality involves transfusing plasma containing high levels of neutralizing antibodies against SARS-CoV-2 into infected patients to neutralize the virus. The therapy was evaluated in a Phase 1, open-label, single-arm study (PENN-CCP-01) specifically targeting severely ill, mechanically ventilated adults with COVID-19 pneumonia.
- Other names
- COVID-19 Convalescent PlasmaCOVID19 Convalescent PlasmaCOVID 19 Convalescent PlasmaConvalescent PlasmaCCP
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on COVID-19 convalescent plasma (University of Pennsylvania).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on COVID-19 convalescent plasma (University of Pennsylvania).